Amedi.sk
Dovoľujeme si Vás upozorniť, že naša web stránka
je určená iba pre odbornú lekársku verejnosť.
Časopis Clinical urology – Článok Urological aspects of tuberous sclerosis complex

Clinical urology

Postgraduate scientific medical journal. Magazine Slovak Association of Urology.
Period 3x per year
1336-7579
The journal is indexed in the Slovak National Bibliography, Bibliographiia Medica Slovaca (BMS) and listed to citation database CiBaMed. All articles are reviewed. The publisher does not bear any responsibility for data and opinions of particular authors of the articles or advertisements. The articles on grey pages are company promotions or non reviewed information, an author is responsible for the content. Any reproduction of the content is allowed only with direct consent of the editorial office.
Predplatné
Clinical urology
Clinical urology
Postgraduate scientific medical journal. Magazine Slovak Association of Urology.
Period 3x per year
Téma: 

Urological aspects of tuberous sclerosis complex

Ján Breza ml., Barbora Novotná

Introduction: Tuberous sclerosis complex is an autosomal dominant hereditary disease that is the result of mutations
in two tumour suppressor genes and is characterised by the formation of benign tumours, hamartomas, in several organ
systems. In about 80 % of cases, the mutations are acquired, the cause of mutation is unknown. Autosomal dominant
gene mutations cause about 20 % of cases of tuberous sclerosis complex, and affliction of more family members
is found. Most commonly, in patients with tuberous sclerosis, neurological and psychiatric symptoms are present. Renal
hamartomas are called angiomyolipomas. After neurological and skin changes, renal angiomyolipomas are ranked
the third in the incidence rate in patients with tuberous sclerosis.
Material and methods: The authors analyse their own clinical experience with the diagnostics and treatment of patients
with the tuberous sclerosis complex. The study includes 12 adult patients (9 women and 3 males aged 17 to 42 years).
Women predominated (75 %) over male patients 25 %).
All patients were polysymptomatic; symptomatology was highly complex and polymorphic. In every patient, the signs
of the simultaneous affliction of at least two organ systems were found. There was no common symptom to all patients,
and no symptom was pathognomonic for the tuberous sclerosis complex. In adult patients, the affliction of the kidneys
by angiomyolipomas was the predominant form of the tuberous sclerosis complex. In most of them, simultaneous signs
of affected skin and nails were observed.
Results: Renal angiomyolipomas were demonstrated in all adult patients with tuberous sclerosis complex. In all cases,
multiple tumours were presented, in 10 patients angiomyolipomas occurred on both sides. All patients complained of
intermittent blunt pain in the lumbar region. In three women, angiomyolipomas manifested dramatically through socalled
Wunderlich syndrome, haemorrhagic shock due to massive retroperitoneal bleeding from the large ruptured angiomyolipoma
of the kidney.
All 9 females underwent surgical treatment of renal angiomyolipomas. In three of them, the kidneys were removed due to
ruptured angiomyolipomas. In one woman, large angiomyolipoma of the kidney (14 cm in diameter) was removed preventively.
As the treatment of renal angiomyolipomas must maintain as much functional parenchyma as possible, in 5 patient
preference was given to nephron sparing surgery in which only the pathological focus is removed from the kidney, but the kidney
was retained. Moreover, two women underwent embolisation of the growing angiomyolipoma with unequivocal results.
The alternative treatment by administration of an inhibitor of the mTOR signalling pathway was considered in 5 patients.
Conclusion: In clinical practice, urologists only rarely meet patients suffering from the tuberous sclerosis complex.
Therefore, experience with the management of this disease is insufficient in affected patients. Diagnostics of tuberous
sclerosis complex is all the more demanding because the patients are usually polysymptomatic, subjective but also objective
symptoms are not specific to the complex of tuberous sclerosis but can also be the signs of other diseases. In all
patients, the signs of simultaneous involvement of at least two organ systems were found. There was not a symptom
common to all patients, and no a symptom was pathognomonic for the tuberous sclerosis complex.
Patients with kidney disease affected by tuberous sclerosis complex should be monitored on a long-term and systematic
basis, in a timely and robust manner, while at the same time complications resulting from kidney angiomyolipomas
must be resolved sparingly.
The complex of tuberous sclerosis is a disease that cannot be prevented. However, based on knowledge and experience,
it is possible to modify the course of the disease, improve the quality of life and extend the survival of some patients.

Klin urol 2017; 13 (3): 125 – 130
CELÝ OBSAH ČLÁNKU JE DOSTUPNÝ IBA PRE PRIHLÁSENÝCH PREDPLATITEĽOV Prihlásiť sa

Ročník 2017  Témy časopisu Clinical urology 3 / 2017

Case study

Nie sú dostupné žiadne voľne dostupné články
CHAIRMAN OF THE EDITORIAL BOARD
prof. MUDr. Ján Kliment, CSc.

MEMBERS OF THE EDITORIAL BOARD
prof. Andrzej Borówka, M.D., PhD.
prof. MUDr. Ján Breza, DrSc.
prof. MUDr. Peter Bujdák, PhD.
prof. MUDr. Tomáš Hanuš, DrSc.
doc. MUDr. Ladislav Jarolím, CSc.
doc. MUDr. Ján Ľupták, PhD.
doc. MUDr. Jozef Marenčák, PhD.
doc. MUDr. Ivan Minčík, PhD.
prof. MUDr. Dalibor Ondruš, DrSc.
prof. Imre Romics, M.D., PhD.
doc. MUDr. Vladimír Študent, PhD.
prof. MUDr. Ján Švihra, PhD.
prof. MUDr. Ladislav Valanský, PhD.
doc. MUDr. František Záťura, PhD.
MUDr. Peter Zvara, PhD.

PROFESSIONAL EDITOR
prof. MUDr. Ján Švihra, PhD.

EDITOR-IN-CHIEF
Ing. Danica Paulenová
e-mail: paulenova@amedi.sk

GRAPHIC LAYOUT AND TYPESETTING
Lucia Vecseiová
e-mail: dtp@amedi.sk

MARKETING MANAGER
Ing. Dana Chodasová
mobil: 0903 224 625
e-mail: marketing@amedi.sk

ECONOMY AND SUBSCRIPTIONS
Ing. Mária Štecková
telefón: 02/55 64 72 48
mobil: 0911 117 949
e-mail: ekonom@amedi.sk

LANGUAGE PROOFREADING
Mgr. Eva Doktorová

PROOFREADING OF ENGLISH TEXTS
Mgr. Jana Bábelová
SECTIONS

OVERVIEW PAPERS
The latest knowledge on disease and disease groups aetiology, pathogenesis, diagnoses and therapy. Maximum extent is 7 pages of text (font ARIAL or TIMES, font size 12, line spacing 1.5). In case of more extensive theme elaboration it is possible to divide the paper to several parts after agreement with editorial office.

ORIGINAL PAPERS
Structuring: introduction, clinical group and methods, results, discussion, conclusion, bibliography

DIAGNOSTIC AND THERAPEUTICAL ALGORITHMS
Diagnosis and therapy processed into tables and schemes, with minimum text, with emphasis on conciseness and clarity.

CASE STUDY
Maximum extent is 3 pages. Structuring: summary, case study, conclusion, bibliography.

MISCELLANEOUS
Reaction to overview articles, news in the field of diagnostics, therapy, trial results (maximum 3 pages), reports from professional events, abstracts from scientific work published abroad, not older than 1 year. Maximum extend is 1 page. Title of the paper in Slovak/Czech, authors, workplace, then title of the paper in English with full citation.


MANUSCRIPT ELABORATION

Write the paper on computer in any common text editor.
write full length of lines (do not use ENTER at the end of a line)
- do not arrange text into columns
- do not do page make-up, put tables at the end of the paper
- distinguish precisely numbers 1, 0 and letters l, O
- use always parentheses ( )
- explain abbreviations always when first used


MANUSCRIPT REQUIREMENTS

1. An accurate paper title, names and surnames of all authors including titles, authors` workplace. The first author address including the phone number, fax and e-mail address.
2. Summary - structured abstract: goal of work, material and methods (do not state the name of the workplace), results, conclusion
3. Key words - in the extent of 3-6.
Write in 1st or 3rd person singular or plural (unify according the type of an article).
4. English translation: the title of the paper, summary, key words 5. Text
If you insert pictures into a document, send also their original files in "jpg" format, create graphs in Excel and send also their original files. If you send photo documentation via post office, please, send just high-class originals. Mark each original by a number, under which it is mentioned in the text. Write in 1st or 3rd person singular or plural (unify according the type of an article). In the text do not use highlighting of the text as e.g. underlined text, bold, with exception of titles, references to pictures, tables, graphs.

6. Bibliography
Citations are numbered chronologically in bold, references in the text are stated by the number of citations in parentheses.
Citation means in general: the surname of the author (authors), title of the work, year of issuing, volume, pages.
Do not use "ét al.", but state all authors.

Examples of citations:
1. Shaheen NJ, Crosby NA, Bozymski EM, et al. Is there publication bias in the reporting cancer risk in Barrett´ esophagus? Gastroenterology 2000; 119: 333-338.
2. Stenestrand U, Wallentin L. Swedish Register of Cardiac Intensive Care (RIKS-HIA): Early statin treatment following acute myocardial infarction and 1-year survival. JAMA 2001; 285: 430-436.
3. LIPID Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998; 339: 1349-1357.
4. Jurkovičová O, Spitzerová H, Cagáň S. Komorové arytmie a náhla srdcová smrť pri akútnom infarkte myokardu. Bratisl Lek Listy 1997; 98: 379-389.
5. Osborne BE. The electrocardiogram of the rat. In: Budden R, Detweiler DK, Zbinden G. The rat electrocardiogram in pharmacology and toxicology. Oxford: Pergamon Press 1981:15-27.

Do not use dots after first names in citations. Do not use colon but dot after names of authors. Use semi-colon after the year of publishing, colon is before pages.

The editorial board reserves the right to make small stylistic changes in the paper. If it is necessary to shorten the paper, the consent of the author will be required. All articles are reviewed.

Which of following factors is not related to rosacea?
a. genetic predisposition
b. Scandinavian origin
c. propionibacterium acnes
d. endothelial growth factor

The editorial board reserves the right to make small stylistic changes in the paper. If it is necessary to shorten the paper, the consent of the author will be required. All articles are reviewed.

All published papers are paid.

Send contributions in the e-mail to the address: paulenova@amedi.sk
Period 3x per year
1336-7579
The journal is indexed in the Slovak National Bibliography, Bibliographiia Medica Slovaca (BMS) and listed to citation database CiBaMed. All articles are reviewed. The publisher does not bear any responsibility for data and opinions of particular authors of the articles or advertisements. The articles on grey pages are company promotions or non reviewed information, an author is responsible for the content. Any reproduction of the content is allowed only with direct consent of the editorial office.
Predplatné
Clinical urology
Clinical urology
Postgraduate scientific medical journal. Magazine Slovak Association of Urology.
Period 3x per year